期刊文献+

缓退瘤联合去势术治疗前列腺癌12例报告

下载PDF
导出
摘要 目的 探讨缓退瘤 (Flutamide)与手术去势联合治疗前列腺癌的疗效。方法 分析 12例经手术去势联合缓退瘤治疗的前列腺癌患者的临床资料。结果  12例经病理证实的前列腺癌患者均行手术去势后口服缓退瘤治疗 ,随访 10例 ,除 1例死于高血压脑率中外 8例完全有效 ,瘤体缩小 (>5 0 % )变软 ,结节消失。 1例出现肝功能损害。结论 缓退瘤与手术去势联合治疗可最大限度地阻断雄激素对前列腺的作用 ,使前列腺癌细胞迅速凋亡 ,从而延长患者的生存期 ,是安全。
机构地区 解放军第
出处 《四川医学》 CAS 2002年第8期820-821,共2页 Sichuan Medical Journal
  • 相关文献

二级参考文献9

  • 1Bono AV. Leuprorelin-continuing advances in the treatment of prostate cancer. Bionledis,1997,2:4.
  • 2okada H, Doken Y,Ogawa Y, et al, Sustaied suppresion of the pituitary gonadal axis by leuororelin three-month depot microspheeres in rats and dogs, Pharmaceutical Research, 1994,11:1199.
  • 3Labrie F,Belanger A,Dupont A.et al.,Science behind total androgen btockade: from gene to combination therapy. Clin Invest Med,1993,16:475.
  • 4Labrie F. At the cutting edge intracrinology.Molecular Cellular Endocrinology, 1991, 78:C113.
  • 5Parmar H, Edwards L, Phillips RH, et al, Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer. Br J Urol, 1987,59:248.
  • 6Neumann F,Kalmus J. Physiological principles of androgen regulation in the hormonal treatment of sexual deviations. Berlio: Diesbach,1991.8-11.
  • 7Niijima T,Aso Y. Clinical phase I ang phase Ⅱstudy on a sustrained release formulation of leuprorelin acetate (TAP- 144-SR) ,an LHIGH Agonist, in patients with promatic cancer. Acta Urotogica Japonica, 1990,36 : 1343.
  • 8Kadar T,Redding TW,Ben D,et al. Receptots for prolactin,somatostatin,and luteininzing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormonereleasing homone and sornatistatin. Proe Natl Acad Sci USA,1988,85:890.
  • 9Paulson DF. Role of endocrine therapy in the managment of prostatic cancer in the skinnner and lieskovsky: Diagnosis and management of genitourinary cancer. Philadelphia: WB SaundersCo, 1988. 464-472.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部